In fact, hyperfibrinolysis leading to hypofibrinogenemia is known to arise from a poor hepatic clearance of tissue plasminogen activator or from reduced hepatic production of fibrinolysis inhibitors. This evidence concerns the gene PLAT and Hypofibrinogenemia.